Cart summary

You have no items in your shopping cart.

    BECN1 Antibody

    Catalog Number: orb1239257

    DispatchUsually dispatched within 5-10 working days
    $ 574.00
    Catalog Numberorb1239257
    CategoryAntibodies
    DescriptionBECN1 Antibody
    Species/HostRabbit
    ClonalityPolyclonal
    Tested applicationsELISA, IF, IHC-P, WB
    Predicted ReactivityBovine, Porcine
    ReactivityHuman, Mouse, Rat
    IsotypeIgG
    ImmunogenAnti-Beclin-1 antibody (orb1239257) was raised against a peptide corresponding to 17 amino acids near the center of human Beclin-1. The immunogen is located between 40-90 amino acids of Beclin-1.
    Concentration1 mg/mL
    Dilution rangeWB: 1 μg/mL; IHC: 2 μg/mL; IF: 20 μg/mL.Antibody validated: Western Blot in human, mouse and rat samples; Immunohistochemistry in human, mouse, and rat samples; Immunofluorescence in human and mouse samples. All other applications and species not yet tested.
    Form/AppearanceLiquid
    ConjugationUnconjugated
    MWPredicted: 52 kDObserved: 60 kD
    TargetBECN1
    UniProt IDQ14457
    NCBIAAH10276
    StorageBeclin-1 antibody can be stored at 4°C up to one year. Antibodies should not be exposed to prolonged high temperatures.
    Buffer/PreservativesBeclin-1 Antibody is supplied in PBS containing 0.02% sodium azide.
    Alternative namesBeclin-1 Antibody: ATG6, VPS30, beclin1, GT197, Be
    Read more...
    NoteFor research use only
    Expiration Date12 months from date of receipt.
    BECN1 Antibody

    WB Validation in Human Cell Lines. Loading: 15 µg of lysate Antibodies: Beclin-1 orb1239257, 1 µg/mL, 1 h incubation at RT in 5% NFDM/TBST. Secondary: Goat Anti-Rabbit IgG HRP conjugate at 1:10000 dilution.

    BECN1 Antibody

    WB Validation in Mouse Cell Lines. Loading: 15 µg of lysate Antibodies: Beclin-1 orb1239257, 1 µg/mL, 1 h incubation at RT in 5% NFDM/TBST. Secondary: Goat Anti-Rabbit IgG HRP conjugate at 1:10000 dilution.

    BECN1 Antibody

    WB Validation in Rat Cell Lines. Loading: 15 µg of lysate Antibodies: Beclin-1 orb1239257, 1 µg/mL, 1 h incubation at RT in 5% NFDM/TBST. Secondary: Goat Anti-Rabbit IgG HRP conjugate at 1:10000 dilution.

    BECN1 Antibody

    Immunofluorescence Validation of Beclin-1 in HELA Cells. Immunofluorescent analysis of 4% paraformaldehyde-fixed Hela cells labeling Beclin-1 with orb1239257 at 10 µg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI antibody (blue).

    BECN1 Antibody

    Immunofluorescence Validation of Beclin-1 in Mouse Brain Tissue. Immunofluorescent analysis of 4% paraformaldehyde-fixed mouse brain cells labeling Beclin-1 with orb1239257 at 20 µg/mL, followed by goat anti-rabbit IgG secondary antibody at 1/500 dilution (green) and DAPI antibody (blue).

    BECN1 Antibody

    Immunohistochemistry Validation of Beclin-1 in Human Brain Tissue. Immunohistochemical analysis of paraffin-embedded human brain tissue using anti-Beclin-1 antibody (orb1239257) at 2.5 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

    BECN1 Antibody

    Immunohistochemistry Validation of Beclin-1 in Mouse Kidney Tissue. Immunohistochemical analysis of paraffin-embedded mouse kidney tissue using anti-Beclin-1 antibody (orb1239257) at 1 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

    BECN1 Antibody

    Immunohistochemistry Validation of Beclin-1 in Rat Liver Tissue. Immunohistochemical analysis of paraffin-embedded rat liver tissue using anti-Beclin-1 antibody (orb1239257) at 1 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

    BECN1 Antibody

    Immunohistochemistry Validation of Beclin-1 in Rat Spleen Tissue. Immunohistochemical analysis of paraffin-embedded rat spleen tissue using anti-Beclin-1 antibody (orb1239257) at 1 µg/ml. Tissue was fixed with formaldehyde and blocked with 10% serum for 1 h at RT; antigen retrieval was by heat mediation with a citrate buffer (pH6). Samples were incubated with primary antibody overnight at 4°C. A goat anti-rabbit IgG H&L (HRP) at 1/250 was used as secondary. Counter stained with Hematoxylin.

    BECN1 Antibody

    Knockdown of Beclin-1 in Human T47D Cells (Thomas et al., 2011). T47D cells were transfected with scrambled or Beclin-1 siRNA. The following day, these cells were treated with vehicle, C, 0.5 mM VPA, 10 lM 4OH-tamoxifen, T, or 0.5 mM VPA and 10 lM 4OH-tamoxifen, VT, for 48 h and viability was assayed by dye exclusion.

    BECN1 Antibody

    Immunofluorescent Validation of Beclin-1 in Human Cortical Neurons and Rat Brain (Wang et al., 2017). Cell specificity of Beclin 1 expression. Cortical neurons and glia co-cultures (upper panels) and cortex slices (lower panels) were immunostainedwith anti-Beclin 1 (red) and NeuN (neuronal biomarker, green) orGFAP (astrocyte biomarker, green). Neurons and astrocytein cultured cells were indicated by arrows and arrowhead, respectively. Areas in white boxes were enlarged.

    BECN1 Antibody

    Immunohistochemistry Validation of Beclin-1 in Human HCC Cells (Qiu et al., 2014). Beclin-1 exhibited cytoplasmic staining in adjacent non-tumor (ANT) tissues (A), bordeling site between HCC and ANT (B: left, ANT; right: HCC), and HCC (C), respectively. Beclin-1 expression was stronger in ANT than in HCC. Magnification × 400.

    BECN1 Antibody

    Regulated Expression of Beclin-1 in Human T47D Cells (Thomas et al., 2011). Treatment with tamoxifen and an HDAC inhibitor alters the balance of autophagy and apoptosis inhibitors and drivers. T47D cells were treated with vehicle, C, 0.5 mM VPA, V, 10 lM 4OHtamoxifen, T, or 0.5 mM VPA and 10 lM 4OH-tamoxifen, VT, for 48 h and Beclin-1 protein and RNA.

    • Beclin 1 antibody [orb10182]

      ICC,  IF,  IHC-P,  WB

      Human, Rat

      Rabbit

      Polyclonal

      Unconjugated

      100 μg, 200 μg
    • Beclin 1/BECN1 Antibody [orb196247]

      FC,  ICC,  IF,  IHC,  WB

      Human, Mouse, Rat

      Rabbit

      Polyclonal

      Unconjugated

      10 μg, 100 μg
    • BECN1 Antibody [orb1274427]

      IF,  IHC,  IP,  WB

      Human, Mouse, Rat

      Rabbit

      Polyclonal

      Unconjugated

      50 μl
    • Beclin 1 antibody [orb33388]

      FC,  IHC-P,  WB

      Porcine, Rat

      Human, Mouse

      Rabbit

      Polyclonal

      Unconjugated

      80 μl
    • Beclin 1 [orb51566]

      ELISA,  IF,  IHC,  WB

      Human, Mouse

      Rabbit

      Polyclonal

      Unconjugated

      100 μg, 50 μg
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars